Ovarian Epithelial Cancer Clinical Trial
Official title:
Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
No structured organization for ovarian first line management emerges in France. Management
across France seems to depend on regional contexts.
Regions display no specific organization or delineate regional network for the ovarian cancer
management or report centralized management revolving around referent centers. These
different templates present a major problem in identifying differences, costs and benefit.
To deal with this issue the Investigators propose a health economic evaluation based on
cost-effectiveness analyses, completed with a budget impact analysis. This study will
investigate the cost-effective management of patients with initial ovarian cancer using
databases representative of different parts of French territories.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
| Active, not recruiting |
NCT01456065 -
Safety of Active Immunotherapy in Subjects With Ovarian Cancer
|
Phase 1 | |
| Recruiting |
NCT06404671 -
Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
|
N/A | |
| Recruiting |
NCT05001282 -
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±)
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03220932 -
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT05937620 -
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer
|
N/A | |
| Completed |
NCT02039388 -
Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
|
N/A | |
| Completed |
NCT02107950 -
Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma
|
Phase 2 | |
| Completed |
NCT02107937 -
Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma
|
Phase 2 | |
| Completed |
NCT01806350 -
Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors
|
N/A | |
| Recruiting |
NCT03349463 -
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
|
Phase 4 | |
| Completed |
NCT04823871 -
Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing
|
N/A | |
| Completed |
NCT02518256 -
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity
|
N/A | |
| Active, not recruiting |
NCT03078400 -
Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT02435186 -
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
|
Phase 2 | |
| Completed |
NCT02489903 -
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
|
Phase 2 | |
| Recruiting |
NCT04029909 -
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
|
Phase 1 | |
| Recruiting |
NCT05498597 -
AMT-151 in Patients With Selected Advanced Solid Tumours
|
Phase 1 | |
| Suspended |
NCT02742428 -
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
|
N/A | |
| Completed |
NCT02062697 -
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.
|
N/A |